$19.560
-0.039 (-0.20%)Zum Schluss
Profitabilität und Margen von SBRA
Evaluating the bottom line, Sabra Health Care REIT, Inc. maintains a gross margin of 62.43%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -13.59%, while the net margin is -10.70%. These profitability ratios, combined with a Return on Equity (ROE) of 2.40%, provide a clear picture of how effectively SBRA converts its operational activities into shareholder value.
SBRA im Vergleich zur Peergroup
In the context of the broader market, SBRA competes directly with industry leaders such as RITM and CUZ. With a market capitalization of $5.00B, it holds a significant position in the sector. When comparing efficiency, SBRA's gross margin of 62.43% stands against RITM's 73.22% and CUZ's 28.27%. Such benchmarking helps identify whether Sabra Health Care REIT, Inc. is trading at a premium or discount relative to its financial performance.
Finanzielle Entwicklung von Sabra Health Care REIT Inc
The company has shown a revenue growth trend, with Q2 2026 revenue at $235.87 million, up from $221.75 million in Q1 2026. However, it reported a net loss of $25.20 million in Q2 2026, which is concerning.
Financials
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.